{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:04:18Z","timestamp":1790928258078,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20FC1052"],"award-info":[{"award-number":["20FC1052"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jid.2022.11.009","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T20:00:49Z","timestamp":1677268849000},"page":"545-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4022-8950","authenticated-orcid":false,"given":"Hisato","family":"Iriki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6768-8821","authenticated-orcid":false,"given":"Hayato","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3314-7052","authenticated-orcid":false,"given":"Masayuki","family":"Amagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2022.11.009_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107648","article-title":"TSLP as druggable target - a silver-lining for atopic diseases?","volume":"217","author":"Adhikary","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jid.2022.11.009_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.651357","article-title":"Peripheral TIGIT+ T follicular helper cells that produce high levels of interleukin-21 via OX40 represent disease activity in IgG4-related disease","volume":"12","author":"Akiyama","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000573","article-title":"New pathways in immune stimulation: targeting OX40","volume":"5","author":"Alves Costa Silva","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.jid.2022.11.009_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jid.2022.11.009_bib5","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/all.13401","article-title":"Epidemiology of atopic dermatitis in adults: results from an international survey","volume":"73","author":"Barbarot","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jid.2022.11.009_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094260","article-title":"Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata","volume":"9","author":"Bertolini","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2022.11.009_bib7","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 family of cytokines in psoriasis: il-17A and beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fimmu.2015.00394","article-title":"Mast cells as regulators of T cell responses","volume":"6","author":"Bulfone-Paus","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/eji.201445163","article-title":"OX40 blockade inhibits house dust mite driven allergic lung inflammation in mice and in\u00a0vitro allergic responses in humans","volume":"45","author":"Burrows","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib10","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2022.11.009_bib11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","article-title":"Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata","volume":"150","author":"Castela","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2022.11.009_bib12","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/annrheumdis-2017-211499","article-title":"B\u00a0cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis","volume":"76","author":"Cortini","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2022.11.009_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-065X.2009.00766.x","article-title":"The significance of OX40 and OX40L to T-cell biology and immune disease","volume":"229","author":"Croft","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jid.2022.11.009_bib14","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.4049\/jimmunol.168.4.1704","article-title":"Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in\u00a0vitro with diverse th cell-polarizing signals","volume":"168","author":"de Jong","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41423-019-0200-x","article-title":"ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice","volume":"17","author":"Deng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib16","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12446","article-title":"Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice","volume":"69","author":"Drake","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jid.2022.11.009_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.anai.2019.10.008","article-title":"The role of filaggrin in atopic dermatitis and allergic disease","volume":"124","author":"Drislane","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41467-021-21383-1","article-title":"Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells","volume":"12","author":"Duhen","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2022.11.009_bib19","doi-asserted-by":"crossref","unstructured":"Eberle FC, Br\u00fcck J, Holstein J, Hirahara K, Ghoreschi K. Recent advances in understanding psoriasis. F1000Res 2016;5:F1000 Faculty Rev-770.","DOI":"10.12688\/f1000research.7927.1"},{"key":"10.1016\/j.jid.2022.11.009_bib20","doi-asserted-by":"crossref","first-page":"adv00099","DOI":"10.2340\/00015555-3452","article-title":"The OX40 axis is associated with both systemic and local involvement in atopic dermatitis","volume":"100","author":"Elsner","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2022.11.009_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.188.2.297","article-title":"CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1","volume":"188","author":"Flynn","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2022.11.009_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.670637","article-title":"The OX40\/OX40L axis regulates T follicular helper cell differentiation: implications for autoimmune diseases","volume":"12","author":"Fu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.imlet.2006.04.001","article-title":"Functional characterization of OX40 expressed on human CD8+ T cells","volume":"106","author":"Fujita","year":"2006","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jid.2022.11.009_bib24","first-page":"10","article-title":"OX40L-OX40 signaling in atopic dermatitis","author":"Furue","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jid.2022.11.009_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/exd.14254","article-title":"Diphenylcyclopropenone plays an effective therapeutic role by up-regulating the TSLP\/OX40L\/IL-13 pathway in severe alopecia areata","volume":"30","author":"Gong","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2022.11.009_bib26","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.4049\/jimmunol.161.12.6510","article-title":"Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses","volume":"161","author":"Gramaglia","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.immuni.2008.08.018","article-title":"CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction","volume":"29","author":"Gri","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.11.009_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.20091618","article-title":"OX40 is required for regulatory T cell-mediated control of colitis","volume":"207","author":"Griseri","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2022.11.009_bib29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jaci.2018.11.053","article-title":"GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis","volume":"144","author":"Guttman-Yassky","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib30","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.immuni.2018.05.003","article-title":"Tissue-restricted adaptive Type 2 immunity is orchestrated by expression of the costimulatory molecule OX40L on Group 2 innate lymphoid cells","volume":"48","author":"Halim","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.11.009_bib31","article-title":"Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRbeta-chain, which highlights the immunopathological aspect of the disease","volume":"14","author":"Hamed","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2022.11.009_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148919","article-title":"Increased frequency of T follicular helper cells and elevated interleukin-27 plasma levels in patients with pemphigus","volume":"11","author":"Hennerici","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2022.11.009_bib33","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.immuni.2011.07.013","article-title":"Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis","volume":"35","author":"Hershko","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.11.009_bib34","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.jaci.2020.11.008","article-title":"Immunophenotyping in pemphigus reveals a TH17\/TFH17 cell-dominated immune response promoting desmoglein1\/3-specific autoantibody production","volume":"147","author":"Holstein","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/1346-8138.15727","article-title":"Psoriasis: recent progress in molecular-targeted therapies","volume":"48","author":"Honma","year":"2021","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2022.11.009_bib36","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","article-title":"Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States","volume":"149","author":"Huang","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2022.11.009_bib37","doi-asserted-by":"crossref","first-page":"13921","DOI":"10.1073\/pnas.1307321110","article-title":"Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice","volume":"110","author":"Imai","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2022.11.009_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026763118","article-title":"Peripheral tolerance by Treg via constraining OX40 signal in autoreactive T cells against desmoglein 3, a target antigen in pemphigus","volume":"118","author":"Iriki","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2022.11.009_bib39","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2022.11.009_bib40","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.immuni.2015.05.012","article-title":"OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response","volume":"42","author":"Jacquemin","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.11.009_bib41","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.4049\/jimmunol.173.8.5247","article-title":"T\u00a0cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells","volume":"173","author":"Kashiwakura","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib42","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Pemphigus. Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2022.11.009_bib43","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jaci.2020.03.036","article-title":"Targeting inducible costimulator expressed on CXCR5(+)PD-1(+) TH cells suppresses the progression of pemphigus vulgaris","volume":"146","author":"Kim","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005374","article-title":"TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation","volume":"5","author":"Kim","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2022.11.009_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ni.3646","article-title":"Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment","volume":"18","author":"Kitagawa","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib46","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00262-020-02501-2","article-title":"Development and characterization of a novel anti-OX40 antibody for potent immune activation","volume":"69","author":"Kuang","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2022.11.009_bib47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/cmi.2018.8","article-title":"Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation","volume":"16","author":"Kumar","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib48","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/annrheumdis-2019-215195","article-title":"Potential involvement of OX40 in the regulation of autoantibody sialylation in arthritis","volume":"78","author":"Kurata","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2022.11.009_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2022.11.009_bib50","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jid.2020.08.015","article-title":"Low-dose IL-2 for treating moderate to severe alopecia areata: a 52-week multicenter prospective placebo-controlled study assessing its impact on T regulatory cell and NK cell populations","volume":"141","author":"Le Duff","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.11.009_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5483\/BMBRep.2021.54.1.242","article-title":"Update of early phase clinical trials in cancer immunotherapy","volume":"54","author":"Lee","year":"2021","journal-title":"BMB Rep"},{"key":"10.1016\/j.jid.2022.11.009_bib52","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.jaci.2020.02.026","article-title":"ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation","volume":"145","author":"Leyva-Castillo","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib53","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1038\/ncomms3847","article-title":"Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade","volume":"4","author":"Leyva-Castillo","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2022.11.009_bib54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ni1445","article-title":"Regulatory T cell development in the absence of functional Foxp3","volume":"8","author":"Lin","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib56","article-title":"Peripheral CD19hi B cells exhibit activated phenotype and functionality in promoting IgG and\u00a0IgM production in human autoimmune diseases","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2022.11.009_bib57","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/j.gastro.2020.03.018","article-title":"Combination of PD-1 inhibitor and OX40 agonist induces tumor rejection and immune memory in mouse models of pancreatic cancer","volume":"159","author":"Ma","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jid.2022.11.009_bib58","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.jid.2021.01.031","article-title":"Rituximab and corticosteroid effect on desmoglein-specific B cells and desmoglein-specific T follicular helper cells in pemphigus","volume":"141","author":"Maho-Vaillant","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.11.009_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33307-z","article-title":"Identification of a Novel OX40L+ dendritic Cell Subset That Selectively Expands Regulatory T cells","volume":"8","author":"Marinelarena","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2022.11.009_bib60","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00403-002-0363-6","article-title":"Expression of CD134 and CD134 ligand in lesional and nonlesional psoriatic skin","volume":"294","author":"Matsumura","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2022.11.009_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102761","article-title":"Engineered antigen-specific regulatory T cells for autoimmune skin conditions","volume":"20","author":"Mukhatayev","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2022.11.009_bib62","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.191.2.365","article-title":"Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand","volume":"191","author":"Murata","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2022.11.009_bib63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jdermsci.2020.06.005","article-title":"Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis","volume":"99","author":"Nakagawa","year":"2020","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.11.009_bib64","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.3390\/ijms21186484","article-title":"Genetic and epigenetic aspects of atopic dermatitis","volume":"21","author":"Nedoszytko","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2022.11.009_bib65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jid.2022.11.009_bib66","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaci.2018.11.015","article-title":"The microbiome in patients with atopic dermatitis","volume":"143","author":"Paller","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib67","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jdv.14313","article-title":"Phase I randomized study of KHK4083, an anti-OX40 monoclonal antibody, in patients with mild to moderate plaque psoriasis","volume":"31","author":"Papp","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2022.11.009_bib68","unstructured":"ClinicalTraials.gov. A study of KY1005. Patients with moderate to severe atopic dermatitis, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03754309; 2018 (accessed 2 October 2021)."},{"key":"10.1016\/j.jid.2022.11.009_bib69","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1158\/1078-0432.CCR-19-1259","article-title":"Anti-OX40 antibody directly enhances the function of tumor-reactive CD8+ T cells and synergizes with PI3Kbeta inhibition in PTEN loss melanoma","volume":"25","author":"Peng","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2022.11.009_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jid.2022.11.009_bib71","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1182\/blood-2009-05-220004","article-title":"Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40\/OX40L axis toward Th17-cell differentiation","volume":"114","author":"Piconese","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.11.009_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627139","article-title":"Gamma Delta T cells and their pathogenic role in psoriasis","volume":"12","author":"Qi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau2042","article-title":"The TNFRSF members CD27 and OX40 coordinately limit TH17 differentiation in regulatory T cells","volume":"3","author":"Remedios","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib74","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coi.2014.10.008","article-title":"Dermal group 2 innate lymphoid cells in atopic dermatitis and allergy","volume":"31","author":"Roediger","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib75","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1074-7613(01)00191-1","article-title":"OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells","volume":"15","author":"Rogers","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.11.009_bib76","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.4049\/jimmunol.0901112","article-title":"Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right","volume":"183","author":"Ruby","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib77","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.vaccine.2005.07.108","article-title":"Regulation of CD4 T cell memory by OX40 (CD134)","volume":"24","author":"Salek-Ardakani","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jid.2022.11.009_bib78","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20021937","article-title":"OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation","volume":"198","author":"Salek-Ardakani","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2022.11.009_bib79","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A\u00a0role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2022.11.009_bib80","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.4049\/jimmunol.175.10.6368","article-title":"Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4\u20131BBL","volume":"175","author":"Serghides","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib81","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1172\/JCI33559","article-title":"In\u00a0vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation","volume":"117","author":"Seshasayee","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2022.11.009_bib82","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2005.03.012","article-title":"Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion","volume":"22","author":"Song","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.11.009_bib83","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.4049\/jimmunol.179.8.5014","article-title":"Differential requirements for OX40 signals on generation of effector and central memory CD4+ T cells","volume":"179","author":"Soroosh","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib84","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/cup.13479","article-title":"Regulatory T-cells in alopecia areata","volume":"46","author":"Speiser","year":"2019","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2022.11.009_bib85","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10238-020-00673-w","article-title":"Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options","volume":"21","author":"Sterkens","year":"2021","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jid.2022.11.009_bib86","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4049\/jimmunol.1601356","article-title":"OX40 cooperates with ICOS to amplify follicular Th cell development and germinal center reactions during infection","volume":"198","author":"Tahiliani","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib87","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.2337\/db15-0188","article-title":"Therapeutic window of interleukin-2 for autoimmune diseases","volume":"64","author":"Tang","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jid.2022.11.009_bib88","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood-2007-01-070748","article-title":"OX40 costimulation turns off Foxp3+ Tregs","volume":"110","author":"Vu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.11.009_bib89","article-title":"Thymic stromal lymphopoietin in cutaneous immune-mediated diseases","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib90","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1172\/JCI34182","article-title":"OX40-OX40L interactions: a promising therapeutic target for allergic diseases?","volume":"117","author":"Wang","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2022.11.009_bib91","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2016.04.019","article-title":"The TNF receptor superfamily in co-stimulating and co-inhibitory responses","volume":"44","author":"Ward-Kavanagh","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.11.009_bib92","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12016-015-8498-3","article-title":"OX40, OX40L and autoimmunity: a comprehensive review","volume":"50","author":"Webb","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105784","article-title":"Critical role of OX40\/OX40L in ILC2-mediated activation of CD4+T cells during respiratory syncytial virus infection in mice","volume":"76","author":"Wu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jid.2022.11.009_bib94","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.2390","article-title":"OX40 signaling favors the induction of T(H)9 cells and airway inflammation","volume":"13","author":"Xiao","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2022.11.009_bib95","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.immuni.2016.05.013","article-title":"The costimulatory receptor OX40 inhibits interleukin-17 expression through activation of repressive chromatin remodeling pathways","volume":"44","author":"Xiao","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.11.009_bib96","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2022.11.009_bib97","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1172\/JCI83871","article-title":"Cancer immunotherapy: harnessing the immune system to battle cancer","volume":"125","author":"Yang","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2022.11.009_bib98","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.celrep.2018.04.048","article-title":"Th1-like Plasmodium-specific memory CD4+ T cells support humoral immunity","volume":"23","author":"Zander","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2022.11.009_bib99","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.2353\/ajpath.2010.100353","article-title":"Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis","volume":"177","author":"Zhang","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2022.11.009_bib100","first-page":"7","article-title":"Activation state of and expressions of surface co-stimulatory molecules on peripheral CD4\u00a0+ T cells from patients with pemphigus","volume":"12","author":"Zhicui","year":"2014","journal-title":"Chin J Dermatol"},{"key":"10.1016\/j.jid.2022.11.009_bib101","article-title":"Clinical significance of OX40 and OX40 ligand in the peripheral blood of patients with myasthenia gravis","volume":"2022","author":"Zhou","year":"2022","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.jid.2022.11.009_bib102","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.jid.2021.01.030","article-title":"The pathogenic role of CD4+ tissue-resident memory T cells bearing T follicular helper-like phenotype in pemphigus lesions","volume":"141","author":"Zou","year":"2021","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22028366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22028366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:29:56Z","timestamp":1758302996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X22028366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0022202X22028366"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2022.11.009","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2022.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}